Well, We Know This Dem Rep Was Asleep at the Wheel During the...
Here's What Was Found in the NYC Federal Plaza Arson Suspect's Cart
It Turns Out Oregon Is Pumping Children Full of Wrong Sex Drugs
In Mamdani's New York City, Open-Air Black Markets for Meds Are Now the...
Remember When Kamala Harris Wanted Paper Ballots for Our Elections?
MS NOW Says All Women Can Lose ALL Rights, via the Mail; NYT...
Check Out Why This WNBA Coach Was Suspended for One Game
Forget Reading, Writing and Arithmetic—Virginia Students Will Learn This Instead
Mamdani Gets Kicked Down for Trying to Take a World Cup Victory Lap
Scott Jennings Says the Democrats Have Already Lost the War to the Socialists
Everyone's Furious About Housing Prices. But Almost No One's Blaming the Right Culprit.
The FDA Still Doesn't Know Who Caused the Diarrhea Parasite Outbreak
Lee Zeldin Blasts the AI Data Center Fear Campaign and Calls on Leaders...
Trump Admin Just Fired Back at Canada Over 'Discriminatory' Actions
Lindsey Graham's Sister Makes Major Announcement About Her Political Future
Tipsheet

Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness

Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness
AP Photo/Jose Luis Magana

President Donald Trump has signed an executive order to speed the use of psychedelic drugs as a potential treatment for serious mental illness. 

The order directs the Food and Drug Administration to the Commissioner’s National Priority Vouchers to appropriate psychedelic drugs that have received breakthrough therapy designations for treating serious mental illnesses. 

Advertisement

That designation aims to ensure that people with serious mental illnesses, including veterans, can receive help. America’s veterans have a suicide rate of twice that of non-veterans. For over 20 years, there have been more than 6,000 veteran suicides per year.

The Order further directs the FDA and the Drug Enforcement Agency to establish a pathway for eligible patients to access investigational psychedelic drugs, including ibogaine compounds, that are under FDA review and that have met basic safety requirements under President Trump’s landmark Right to Try Act.

The Order requires the Secretary of Health and Human Services to allocate $50 million through the Advanced Research Projects for Health program to match investments made by state governments to advance research into psychedelic programs for populations with serious mental illness.

The HHS and FDA will collaborate with the Department of Veterans Affairs and the private sector to increase clinical trial participation and evidence generation surrounding experimental psychedelic therapies. 

The order tells the Attorney General to review these drugs upon successful completion of Phase 3 clinical trials so they can be rescheduled, if appropriate. 

Advertisement

Today, over 14 million American adults have a serious mental illness— a diagnosable mental, behavioral, or emotional disorder that substantially interferes with a person’s life and ability to function.


Advertisement



Editor’s Note: Do you enjoy Townhall’s conservative reporting that takes on the radical Left and woke media? Support our work so that we can continue to bring you the truth.

Join Townhall VIP and use promo code FIGHT to receive 60% off your membership.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement